Intervacc is trading 8.19% up at €0.06 on October 20, 2026, with no confirmed catalyst for the move.

  • The company’s press-release page lists July 30 and July 29 as its latest releases, with no release dated October 19 or 20.
  • Available market context points to a biotech-sector tailwind, but no reliable report links it to Intervacc’s gain; the reason remains uncertain.